Notas de prensa

  • 1 de noviembre de 2007
  • 221

Call for Applications: The Amgen Award for Science Teaching Excellence

32 Outstanding Teachers Will Be Recognized in Communities Where Amgen Operates

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Nov. 1, 2007--Amgen (NASDAQ:AMGN) today announced that it now invites applications for its 17th annual Amgen Award for Science Teaching Excellence. This award is designed to recognize and honor extraordinary science teachers at the K-12 level, who significantly impact their students through exemplary science teaching and who achieve demonstrated results in student learning in communities where Amgen operates.

With a longstanding commitment to science education, Amgen established the teacher awards program to promote and encourage science excellence in public and private schools. Since the program´s inception in 1992, Amgen has awarded more than $1.7 million to educators who have made exceptional science-teaching contributions and who have significantly impacted the lives of their students. Amgen is expanding its program this year, and will honor a total of 32 teachers in California, Colorado, Kentucky, Massachusetts, Puerto Rico, Rhode Island, Washington and Canada (British Columbia and Ontario).

"An inspirational teacher can truly make a difference for students," said Phyllis Piano, vice president Corporate Communications and Philanthropy. "Amgen is proud to honor educators who inspire their students to learn more about the wonders of science."

The 32 selected winners within the United States, Puerto Rico and Canada will receive the following benefits:

-- An unrestricted cash award of $5,000USD or $5,000CAD; -- A restricted $5,000USD or $5,000CAD cash grant to the recipient´s school for the expansion or enhancement of a school science program, science resources, or the professional development of the school´s science teachers

Applicants are also required to submit an innovative lesson plan that they have successfully incorporated into their classroom and can be shared with other teachers. A panel of independent judges will select the winners based on the following criteria: creativity of teaching methods; innovative lesson plan; effectiveness in the classroom and the plan for the use of grant money to improve science education resources in their schools.

A select number of the lesson plans submitted by 2008 AASTE Award winners will be posted to Amgen´s Web site, with the intent that other teachers will benefit from these innovative materials. Select lesson plans from 2007 AASTE Award winners are available for download at no cost; educators are encouraged to review and implement any of these plans into their own curriculum.

Those interested in applying should visit http://www.amgen.com/citizenship/aaste.html for more information. Applications must be postmarked by Jan. 31, 2008 to be valid. Winners will be notified in May 2008.

About Amgen

Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science´s promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people´s lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

CONTACT: Amgen, Thousand Oaks Sarah Rockwell, 805-447-9953 (media) SOURCE: Amgen

Destacadas

  • XIV Curso de Cáncer Hereditario de SEOM

    Farmanews Farmanews

    XIV Curso de Cáncer Hereditario de SEOM

    Leer más
  • Giromed Institute y Pangaea Oncology crean Pectus Respiratory Health e inaugurarán un centro de investigación de enfermedades respiratorias en Girona

    Patricia Morén

    Giromed Institute y Pangaea Oncology crean Pectus Respiratory Health e inaugurarán un centro de investigación de enfermedades respiratorias en Girona

    Leer más
  • Las presentaciones atípicas pueden retrasar el diagnóstico de la XLH en hasta un 50% de los pacientes

    Alba Martín

    Las presentaciones atípicas pueden retrasar el diagnóstico de la XLH en hasta un 50% de los pacientes

    Leer más

Newsletter

Suscríbete para conocer las novedades del mundo farmacéutico y sanitario.

¿Qué es?

FarmaNews pone a disposición de los medios y departamentos de comunicación, un canal para publicar notas de prensa y convocatorias del mundo sanitario y farmacéutico.

Contacto

Avda. Mare de Déu de Lourdes, 108,
08757, Corbera de Llobregat
(Barcelona), España